Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
10.1016/j.omto.2020.11.004 56 GwonM
People with severe obesity will be able to access the drugs via Medicare at a $50 co-pay, starting as soon as mid-2026
Exendin-4 is a high potency agonist and truncated exendin-(939)-amide an antagonist at the glucagon-like peptide 1-(736)-amide receptor of insulin-secreting beta-cells
Nat Rev Endocrinol (2018) 14(5):27084
Fller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F
US$ 22.39
US$ 24.16
US$ 24.71
US$ 28.81
US$ 26.05
US$ 21.10
US$ 22.80
US$ 21.00
US$ 28.90
US$ 22.89
US$ 21.43
US$ 28.06
US$ 26.58
US$ 26.01
